|
🐜
|
Development of the Bipolar Inventory of Symptoms Scale
8 auth.
C. Bowden,
Vivek Singh,
P. Thompson,
Jodi M. Gonzalez,
M. Katz,
M. Dahl,
...
T. Prihoda,
X. Chang
|
6 |
2007 |
6
🐜
|
|
🐜
|
Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability
7 auth.
Jodi M. Gonzalez,
C. Bowden,
M. Katz,
P. Thompson,
Vivek Singh,
T. Prihoda,
...
M. Dahl
|
5 |
2008 |
5
🐜
|
|
🐜
|
Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.
9 auth.
Jodi M. Gonzalez,
P. Thompson,
M. Escamilla,
Mako Araga,
Vivek Singh,
N. Farrelly,
...
M. Thase,
D. Miklowitz,
C. Bowden
|
4 |
2007 |
4
🐜
|
|
🐜
|
Increasing minority research participation through collaboration with community outpatient clinics: the STEP-BD Community Partners Experience
7 auth.
Jane Kogan,
M. Bauer,
E. Dennehy,
D. Miklowitz,
Jodi M. Gonzalez,
P. Thompson,
...
G. Sachs
|
3 |
2009 |
3
🐜
|
|
🐬
|
P.2.e.016 Sensitivity of a comprehensive rating scale for bipolar disorders to assess improvements with treatment
C. Bowden,
J. Mintz,
J. Gonzalez,
V. Singh,
P. Thompson,
C. Bernardo
|
0 |
2009 |
0
🐬
|
|
🐢
|
P237. Proteomics Analyses of Oligodendrocyte Specific Markers in Major Depressive Disorder and Suicidality
9 auth.
Bharathi S. Gadad,
J. Medrano,
Valeria Diaz-Pacheco,
Maria Vanessa-Jimenez,
Victoria Diaz,
Andrew Lemoff,
...
Ming-Ying Leung,
Charles Spencer,
P. Thompson
|
0 |
2022 |
0
🐢
|
|
🐜
|
514. Brain-Cell Type Proteomics Analyses Specific to Oligodendrocyte in Postmortem Brain Subjects With Major Depressive Disorder and Suicidality
7 auth.
J. Medrano,
Charles Spencer,
Enrique Ramos,
Alejandra Ruiz-Velasco,
Andrew Lemoff,
P. Thompson,
...
Bharathi S. Gadad
|
0 |
2023 |
0
🐜
|
